Sign Up Today and Learn More About Tally Health Stock
Invest in or calculate the value of your shares in Tally Health or other pre-IPO companies through EquityZen's platform.
Tally Health Stock (TAHE)
Tally Health™ is a biotechnology company founded to change the way we age. Co-founded by longevity expert Dr. David Sinclair.
About Tally Health Stock
Founded
2021
Headquarters
New York, NY, US
Industries
Messaging and Telecommunications, Content and Publishing, Sports
Tally Health™ is a biotechnology company founded to change the way we age. Co-founded by globally renowned longevity expert Dr. David Sinclair, Tally Health’s proprietary diagnostic test and individualized interventions give members the science-backed tools to live healthier, longer. The Company was incubated and is backed by L Catterton, the largest global consumer-focused private equity firm. To learn more about Tally Health, visit tallyhealth.com.
Tally Health Press Mentions
Stay in the know about the latest news on Tally Health
Tally Health CEO Melanie Goldey On Wellness, Aging And Beauty Sleep
forbes • May 19, 2024
Tally Health launches pro-longevity sleep supplement
longevity • Apr 14, 2024
Tally Health Review – Forbes Health
forbes • Apr 09, 2024
Tally Health announces innovative next-gen epigenetic age clock
longevity • Mar 05, 2024
How Old Are You Really? 3 New Tests Will Determine Your ...
menshealth • Jan 27, 2024
Investors in Tally Health
Discover investors in Tally Health stock and explore their portfolio companies
Tally Health Management
Leadership team at Tally Health
Chief Executive Officer
Melanie Goldey
Board of Directors
Kirsten Green
Join now and verify your accreditation status to gain access to:
- Tally Health Current Valuation
- Tally Health Stock Price
- Tally Health Management
- Available deals in Tally Health and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Tally Health Cap Table and Funding History by Share Class and Liquidity Preferences
- Tally Health Revenue and Financials
- Tally Health Highlights
- Tally Health Business Model
- Tally Health Risk Factors
- Tally Health Research Report from SACRA Research
Trading Tally Health Stock
How to invest in Tally Health stock?
Accredited investors can buy pre-IPO stock in companies like Tally Health through EquityZen funds. These investments are made available by existing Tally Health shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Tally Health stock?
Shareholders can sell their Tally Health stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
